FILTER

LATEST ARTICLES

Québec’s Aerospace 4.0: A Solution to Cost Pressures?

June 02, 2017
As cost pressures propagate from OEM’s down the value chain, does Industry 4.0 hold the solutions?

Innovation: The Industry’s Backbone

May 24, 2017
The cost of developing new drugs and cures is enormous. A delicate balance between encouraging innovation and controlling the cost of medicines has to be maintained.

Engineering: The 'Sponge' Factor

May 24, 2017
After significant downsizing and diversification, the mining-related workload will increase again for consultancy companies.

Drillers Busy Once Again in British Columbia and Yukon

May 24, 2017
After some very difficult years, juniors and producers are once again exploring and in needs of rigs.

Singapore Aerospace: Satellite Communications

May 11, 2017
Solving an age-old problem that vexes all commercial Low Earth Orbit Satellites.

Ontario Aerospace

May 11, 2017
Ontario’s Aerospace Sector relies on a powerful manufacturing and industrial heritage.

Logistics and Distribution: From Factory to Patient

May 09, 2017
Consolidation and the requirements of new and personalized drugs are changing the playing field.

The Junior Segment: Picking Up

April 28, 2017
After years of very low market conditions in Peru, it is refreshing to see project developers and explorers coming back to life.

Lithium, Uranium, Graphite, and Cobalt: The Trend Takes Hold in WA

April 28, 2017
WA is well set to become the world’s major supplier for the minerals required for electric batteries.

Production and Exploration Overview

April 03, 2017
New production caused Peru’s copper output to increase 70% between 2014 and 2016 assuring the nation's place as the second global producer. GBR looks at Peru’s growing production of metals and minerals.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.

PARTNER EVENTS